Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Pavandeep Ghataorhe"'
Autor:
Christopher J. Rhodes, Min Li, Aneta Gandjeva, B. Alexandre McKeon, Rui-Sheng Wang, Joshua M. Thurman, Jane A. Leopold, Hui Zhang, Rubin M. Tuder, V. Michael Holers, Sushil Kumar, Jennifer Laskowsky, Timothy M. Sullivan, Mehdi A. Fini, Samantha Hu, Bradley A. Maron, Pavandeep Ghataorhe, Maria G. Frid, Martin R. Wilkins, Kurt R. Stenmark
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
Rationale: Pulmonary hypertension (PH) is a life-threatening cardiopulmonary disorder in which inflammation and immunity have emerged as critical early pathogenic elements. Although proinflammatory processes in PH and pulmonary arterial hypertension
Autor:
Malin Hultcrantz, David Kleinman, Pavandeep Ghataorhe, Astrid McKeown, Wei He, Thomas Ling, Roxanne C. Jewell, Julie Byrne, Laurie Eliason, Emma Scott, Joanna Opalinska
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S184
Autor:
Malin Hultcrantz, David Kleinman, Pavandeep Ghataorhe, Astrid McKeown, Wei He, Thomas Ling, Roxanne C. Jewell, Julie Byrne, Laurie Eliason, Emma Scott, Joanna Opalinska
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S425
Autor:
Malin Hultcrantz, David Kleinman, Pavandeep Ghataorhe, Astrid McKeown, Wei He, Thomas Ling, Roxanne C. Jewell, Julie Byrne, Laurie Eliason, Emma Catherine Scott, Joanna Opalinska
Publikováno v:
Journal of Clinical Oncology. 40:TPS8073-TPS8073
TPS8073 Background: Belantamab mafodotin (belamaf: BLENREP) is a first-in-class, monomethyl auristatin F (MMAF)-containing, B-cell maturation antigen (BCMA)-directed antibody–drug conjugate (ADC). In the DREAMM-2 study, belamaf showed deep response
Autor:
Malin Hultcrantz, Thomas Ling, Emma C. Scott, Laurie Eliason, Julie Byrne, Joanna Opalinska, Wei He, Pavandeep Ghataorhe, Joseph Brunner, Roxanne C. Jewell, David M. Kleinman, Astrid McKeown
Publikováno v:
Blood. 138:1645-1645
Introduction: Belantamab mafodotin is a first-in-class, monomethyl auristatin F (MMAF)-containing, B-cell maturation antigen (BCMA)-directed antibody-drug conjugate (ADC) that is approved in the United States and European Union for adult patients wit
Autor:
John Wharton, Christopher J. Rhodes, Martin R. Wilkins, Lars Harbaum, Pavandeep Ghataorhe, Mark I Attard
Publikováno v:
Journal of Internal Medicine. 282:129-141
Pulmonary arterial hypertension (PAH), at one time a largely overlooked disease, is now the subject of intense study in many academic and biotech groups. The availability of new treatments has increased awareness of the condition. This in turn has dr
Autor:
Martin R. Wilkins, Dolores Taboada, John Cannon, Christopher J. Rhodes, Pavandeep Ghataorhe, Kasia Zalewska, Mark Toshner, Emilia M. Swietlik, John Wharton, Nicholas W. Morrell, Joanna Pepke-Zaba, Luke Howard
Publikováno v:
The European Respiratory Journal
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Pulmonary hypertension is a condition with limited effective treatment options. Chronic thromboembolic pulmonary hypertension (CTEPH) is a notable exception, with pulmonary endarterectomy (PEA) often proving curative. This study investigated the plas
Autor:
Lars, Harbaum, Pavandeep, Ghataorhe, John, Wharton, Beatriz, Jiménez, Luke S G, Howard, J Simon R, Gibbs, Jeremy K, Nicholson, Christopher J, Rhodes, Martin R, Wilkins
Publikováno v:
Thorax. 74(4)
Aberrant lipoprotein metabolism has been implicated in experimental pulmonary hypertension, but the relevance to patients with pulmonary arterial hypertension (PAH) is inconclusive.To investigate the relationship between circulating lipoprotein subcl
Autor:
Pavandeep Ghataorhe, Martin R. Wilkins, Christopher J. Rhodes, John Wharton, Mark P. Lythgoe, Mark I Attard
The past three decades have witnessed a welcome expansion of the therapeutic armamentarium for the management of pulmonary arterial hypertension (PAH). However, against this backdrop, there have been some notable disappointments in drug development.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dffae7ec9e35a162b8edce055849100
http://hdl.handle.net/10044/1/32478
http://hdl.handle.net/10044/1/32478
Autor:
Jeffrey A. Norton, Pamela Trapane, Angela Pickart, James M. Ford, Pavandeep Ghataorhe, Kerry Kingham, Allison W. Kurian
Publikováno v:
Cancer Genetics and Cytogenetics. 179:89-92
High-penetrance autosomal dominant cancer susceptibility genes such as BRCA2 and MEN1 result in specific patterns of cancers in individuals who inherit germline mutations. Their incidence in the population is relatively low, however, and it is highly